Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia. (Q45871229)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

0 references

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

K E Webert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

D M Arnold

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J Carruthers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

L Molnar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

T Almonte

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

K Decker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

W Seroski

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J Reed

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M Pai

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

I R Walker

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

1 September 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

518-526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17880438%20AND%20SRC:MED&resulttype=core&format=json

Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

Clinical picture and treatment strategies in factor VII deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

Treatment of severe coagulopathy after gunshot injury to the head using recombinant activated factor VII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

Use of recombinant activated factor VII to treat the acquired coagulopathy of trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

Challenges in the therapeutic use of a "so-called" universal hemostatic agent: recombinant factor VIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

"Off-license" use of recombinant activated factor VII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

Recombinant activated factor VII for acute intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

Thromboembolic adverse events after use of recombinant human coagulation factor VIIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

Transfusion medicine service policies for recombinant factor VIIa administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

Developing a tracking system for coagulation factor concentrates in southern Ontario.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X

Recombinant coagulation factor VIIa in major liver resection: a randomized, placebo-controlled, double-blind clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2516.2007.01490.X